Plain-English translation of NCT06402188 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study evaluates the safety and effectiveness of the ColoSeal ICD System, a protective device placed inside the colon during cancer surgery to protect the newly created surgical connection (called an anastomosis) from stool contact. The device is inserted through the rectum without additional incisions and stays in place for about 10–14 days while the surgical site heals. After that time, doctors confirm healing is complete and remove the device.
After surgery to remove rectal or colon cancer, the surgeon must reconnect the healthy sections of colon. This new connection is vulnerable to leaks during early healing, which can lead to serious complications. This trial aims to see whether protecting that area from stool contact can reduce these risks and improve recovery.
You likely qualify if…
You likely don't qualify if…
You will undergo your planned colon cancer surgery as scheduled. During surgery, after the surgeon creates the new connection, the ColoSeal device will be inserted through the rectum and positioned to protect the surgical site. The device has an external collection bag attached to your skin to gather stool. You will keep the device in place for about 10 days while you recover at home, then return to the hospital for a healing check. Once the surgeon confirms the surgical site has healed properly, the device is removed in a simple outpatient procedure.
AI-generated summary from trial data · Jun 29, 2026 · Not medical advice
Armenia
Georgia
Uzbekistan